Treatment of leptomeningeal relapse of medulloblastoma with temozolomide [2]

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 7, 2002, Pages 591-593

  Hongeng, Suradej ^a   Visudtibhan, Anannit ^a   Dhanachai, Mantana ^a   Laothamatus, Jiraporn ^a   Chiamchanya, Surang ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

CASE REPORT; CHILD; DRUG EFFICACY; HEADACHE; HUMAN; HYDROCEPHALUS; LETTER; MALE; MEDULLOBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; VOMITING;

EID: 0036817236     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200210000-00024     Document Type: Letter

References (5)

1. Biasco G, Pantaleo MA, Casadei S. Treatment of brain metastases of malignant melanoma with temozolomide. N EngL J Med 2001;345:621-2.
2. Yung WKA, Albright RE, Olson J, et al. A phase II study of temozolomide versus procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000;83:588-93.
3. Agarwala SS, Reyderman L, Statkevich P, et al. Pharmacokinetic study of temozolomide penetration into CSF in a patient with dural melanoma [abstract]. Ann Oncol 1998;9(suppl 4):138.
4. Friedman HS, Dolan ME, Pegg AE, et al. Activity of temozolomide in the treatment of central nervous system tumor xenografts. Cancer Res 1995;55: 2853-7.
5. Dunkel IJ, Boyett JM, Yates A, et al. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 1998;16:222-8.